Testing effectiveness (Phase 2)Study completedNCT02828111
What this trial is testing
Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas
Who this might be right for
Basal Cell Carcinomas
PellePharm, Inc. 36